G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon (Glucagon for Injection [RDNA Origin]) for Induced Hypoglycemia Rescue in Adult Patients With T1DM: A Phase 3, Multi-center, Randomized, Blinded, 2-Way Crossover Study to Evaluate Efficacy and Safety
Phase of Trial: Phase III
Latest Information Update: 31 May 2017
At a glance
- Drugs Glucagon (Primary)
- Indications Hypoglycaemia
- Focus Registrational; Therapeutic Use
- Sponsors XERIS Pharmaceuticals
- 12 Feb 2017 Planned End Date changed from 1 Aug 2016 to 1 Sep 2017.
- 12 Feb 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Aug 2017.
- 12 Feb 2017 Status changed from not yet recruiting to recruiting.